Skip to main content UK The UK's free public sector contract intelligence platform. 160,000+ live opportunities from every official UK procurement portal.
PA23 Ready UK Data Daily Updates
BidWriter Found a contract? BidWriter drafts, scores and manages the bid — AI bid writing from your own evidence.
eSourcing OS For buyers. The platform contracting authorities run their tenders, frameworks and DPS on.
See eSourcing OS → 🇺🇸 WinAContract InternationalBidding on US federal & state contracts? Use our American platform:
© 2026 eSourcing Data Ltd · Company No. 16391108 Registered in England & Wales
Data sourced under Crown Copyright from official UK government portals 🇬🇧
Loading contract search results…
Loading contract details…
#2c3e50#3aaee0
Awarded: NHS National Generic Pharmaceuticals Wave 14c | Accord-UK Ltd | WinAContract
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2) Public Sector Award notice Closed SME-friendly
Source: Contracts Finder Notice Type: Award notice Buyer: NHS England Main Category: Goods Procurement Method: Open procedure (above threshold) Tender Status: Closed Estimated Value (ex. VAT):
Award outcome Awarded to (63 suppliers)
Accord-UK Ltd GB-CFS-165037
Macure Pharma ApS GB-CFS-215206
Neon Healthcare Ltd GB-CFS-215237
Bristol Laboratories Limited GB-CFS-215231
Syri Limited (T/A Thame Laboratories) GB-CFS-215187
Arcadia Pharma Ltd T/A Arcadia Medical GB-CFS-233009
Kyowa Kirin Ltd GB-CFS-209871
Waymade PLC GB-CFS-255325
Dr Falk Pharma UK Ltd GB-CFS-215200
Description Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)
About NHS England Published contracts in the last 12 months
£251,986,446
average contract size
Typical categories
Education and training services Medical equipments, pharmaceuticals and personal care products
Add to pipelineImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Save Alert me Share this contractApplication Deadline
23 November 2023
Closed
Estimated Value
£424,035,364
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation → Application Deadline: 23 November 2023
Contract Start Date: 31 May 2024
Contract End Date: 31 May 2027
Contract Duration: 3.0 years
Procurement ID (OCID): ocds-b5fd17-473f438e-1571-48a1-aa1d-5a4342588eda
Notice Reference: c3b17fe3-6ef4-4a0a-a5ef-4a4939328e53-750815
View Original Notice
Access the full notice on the official portal
Lupin Healthcare (UK) Limited
GB-CFS-215229
Crescent Pharma Ltd GB-CFS-215225
Chiesi Limited GB-CFS-186555
Strides Pharma Uk LTD GB-CFS-209875
Galvany Pharma Ltd GB-CFS-255298
Drugsrus Ltd GB-CFS-283415
Aspen Pharmacare UK Limited GB-CFS-283416
MSN Laboratories Europe Limited GB-CFS-255307
Scope Ophthalmics GB-CFS-283417
Stirling Anglian Pharmaceuticals Ltd GB-CFS-209874
Eramol (UK) Ltd GB-CFS-283418
AOP Orphan Ltd GB-CFS-233006
Thea Pharmaceuticals Limited GB-CFS-232999
Relonchem Ltd GB-CFS-215220
Ferring Pharmaceuticals Ltd GB-CFS-183751
Torrent Pharma UK Ltd GB-CFS-209882
JCSH Pharma Ltd GB-CFS-255323
Lundbeck Limited GB-CFS-215217
Takeda UK Ltd GB-CFS-183750
Reckitt Benckiser GB-CFS-215214
Strandhaven Ltd t/a Somex Pharma GB-CFS-283420
Brown & Burk UK Ltd GB-CFS-255315
Tillomed Laboratories ltd GB-CFS-186545
Baxter Healthcare Ltd GB-CFS-255309
Galen Limited GB-CFS-209878
Reig Jofre UK limited GB-CFS-283421
Necessity Supplies Limited GB-CFS-209883
Medley Pharma Ltd GB-CFS-283422
Manx Healthcare Ltd GB-CFS-215211
LogixX Pharma Ltd GB-CFS-215216
Evolan Pharma GB-CFS-282191
Ascend Laboratories UK Ltd GB-CFS-226314
Rivopharm UK Ltd GB-CFS-215241
Norgine Pharmaceuticals Limited GB-CFS-255312
Vantage Pharmaceuticals Ltd GB-CFS-233018
Genesis Pharmaceuticals Ltd GB-CFS-283423
Focus Pharmaceuticals Ltd GB-CFS-209884
Correvio GmbH GB-CFS-283424
Beaumont Pharma Ltd GB-CFS-255311
Oralieve UK Ltd GB-CFS-209879
Orion Pharma (UK) Ltd GB-CFS-283425
Recordati Pharmaceuticals Ltd GB-CFS-255308
Clydesdale Pharma ltd GB-CFS-283426
RPH Pharmaceuticals AB GB-CFS-215223
Tetris Pharma Lts GB-CFS-233021
Uni Health Distribution Ltd GB-CFS-282194
Award value: £1 Award decision date: 4 March 2024 Award status: Active